Suchergebnisse - "Langer, Jakob"

PubPharm (4)

1

Retrospective real-world adherence in patients with type 2 diabetes initiating once-daily liraglutide 1.8 mg or twice-daily exenatide 10 μg

enthalten in: Clinical therapeutics | 2013

von Malmenäs, M. | Bouchard, J. | Langer, J.

2

Retrospective Real-World Adherence in Patients With Type 2 Diabetes Initiating Once-Daily Liraglutide 1.8 mg or Twice-Daily Exenatide 10 μg

enthalten in: Clinical therapeutics | 2013

von Malmenäs, M. | Bouchard, J. | Langer, J.

3

Evaluating the long-term cost-effectiveness of liraglutide versus exenatide BID in patients with type 2 diabetes who fail to improve with oral antidiabetic agents

enthalten in: Clinical therapeutics | 2011

von Valentine, W. | Palmer, A. | Lammert, M. | +2

4

Evaluating the Long-Term Cost-Effectiveness of Liraglutide Versus Exenatide BID in Patients With Type 2 Diabetes Who Fail to Improve With Oral Antidiabetic Agents

enthalten in: Clinical therapeutics | 2011

von Valentine, W. | Palmer, A. | Lammert, M. | +2

1
[1]